Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Clinical results presented for Knoll's PEG-hirudin

Sep. 30, 1997

SKB reports new antiplatelet agents

Sep. 29, 1997

Astra describes prodrugs of thrombin inhibitors

Sep. 26, 1997

rNAPc2 completes phase Ia testing with positive results

Sep. 25, 1997

Lilly presents structurally novel thrombin inhibitors

Sep. 24, 1997

First approvals for Lovenox/Clexane in unstable angina/MI

Sep. 22, 1997

TP-9201 as adjunct to thrombolysis in stroke

Sep. 22, 1997

Lilly describes lead for orally active thrombin inhibitors

Sep. 19, 1997

Bisulfated peptide may be clinically useful in venous thrombotic disorders

Sep. 17, 1997

Long-term effects of abciximab in PTCA

Sep. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...